SERES THERAPEUTICS INC earnings per share and revenue

1S9 earnings per share for the last quarter are 0.52 EUR whereas the estimation was -0.07 EUR which accounts for 848.09% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 27.84 M EUR. Estimated earnings per share for the next quarter are -0.19 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of 1S9 earnings per share and revenue dynamics.